Risk Prediction Model for Early Hodgkin's Lymphoma Outperforms Widely Used Standard

(MedPage Today) -- A prognostication tool for early classic Hodgkin's lymphoma (cHL) outperformed a widely used classification system in predicting 2-year progression-free survival (PFS), according to training and validation studies involving more...